Rising healthcare investment drives cold-form blister packaging demand, states Fact.MR

According to Fact.MR, a market research and competitive intelligence provider, the global cold form blister packaging market is estimated to reach a valuation of US$ 1,123.6 million in 2024 and is expected to grow at a CAGR of 6.0% during the forecast period of 2024 to 2034.

Increasing health investments across the world are building huge demand for cold-form blister packs, mostly in the developing economies, which have been witnessing the growth of pharmaceutical industries. Governments and private sectors are making considerable investments into the health infrastructure to increase the production as well as the dispensation of drugs. Cold-form blister packing is essential to maintain the product safety that ensures drug efficiency, especially in this regard of the growing regulatory scrutiny.

Providers will have to be innovative with environment-friendly material, advanced manufacturing technologies, and region-specific packaging solutions through strategic collaborations with pharmaceutical companies to better fit fast-growing economies in sustainability goals thus solidifying market presence. Such strategies promise to put companies in a position to exploit new opportunities opening through this shifting landscape of healthcare.

For More Insights into the Market, Request a Sample of this Report:

https://www.factmr.com/connectus/sample?flag=S&rep_id=7824

Key Takeaways from the Market Study

• The global cold form blister packaging market is projected to grow at 6.0% CAGR and reach US$ 2,012.2 million by 2034. The market created an opportunity of US$ 888.6 million between 2024 and 2034
• North America is a prominent region that is estimated to hold a market share of 24.3% in 2034. Predominating market players include Essentra plc, Amcor plc, & Bilcare Limited
• The pharmaceuticals type of application is estimated to grow at a CAGR of 6.0%, creating an absolute $ opportunity of US$ 490.7 million between 2024 and 2034. Aluminum under the material type in cold form blister packaging market is expected to reach US$ 500 million by 2024

“Increased pharmaceutical production drives need for effective packaging solutions,” says a Fact.MR analyst.

Development by Market Players in Cold Form Blister Packaging Market

Aphena Pharma Solutions, Inc.: October, 2022, Aphena Pharma Solutions, Inc. disclosed that the US$ 20 million expansion and renovation which commenced in mid-2019 in Cookeville, Tennessee, has now been finalized, increasing significantly solid dose packaging capacity available.

Growing need for safe and non-tampering packaging solutions in the pharmaceutical industry

Cold blister packing has become a highly sought-after product for the pharmaceutical sector, particularly in light of the growing demands for primary packaging that is secure, tamper-proof, and suitable for purpose. The format offers the perfect defense against all sorts of external factors, including as oxygen, moisture, and even contaminants that might impair the effectiveness of the medications or, in the event of environmentally sensitive medications, the packing materials.

The integrity of the drug and patient safety are guaranteed by tamper-resistant features in cold-form blister packaging, such as opaque, sealed foils that prohibit unwanted access and modifications. Due to increased regulatory oversight and pharmaceutical businesses' emphasis on following safety regulations, tamper-resistant packaging has emerged as a crucial measure in lowering the hazards associated with misuse, contamination, and counterfeiting.

This is especially true for high-value and over-the-counter medications, where consumers choose unit-dose packaging that is easy to use and safe. In light of this overall trend, there is a critical need for safe packaging solutions that can maintain product quality while adhering to safety and regulatory requirements in the worldwide pharmaceutical industry.

Get Customization on this Report for Specific Research Solutions:

https://www.factmr.com/connectus/sample?flag=S&rep_id=7824

Longer product shelf life is advantageous to producers and consumersIn cold-form processes, blister packing extends shelf life and offers significant advantages to both producers and customers. Pharmaceuticals in particular benefit from an airtight, protective seal that shields the product from light, oxygen, and moisture, which are the main causes of product deterioration. For the customer, this implies longer-lasting medications that are more effective and safe, which promotes fewer frequent purchases and less waste. Manufacturers benefit from lower waste, lower operational costs, and more product availability due to longer shelf life.

Manufacturers can provide the market from farther away without compromising quality thanks to extended shelf life, which helps the industry grow. Cold-form blister packaging gives businesses a useful way to comply with stringent regulations, which nonetheless place a strong emphasis on the products' stability. Cold-form blister packaging is popular in the market because it is sturdy and protects against damage, which increases customer trust while also helping it operate more efficiently.

Key Companies Profiled:

• Amcor plc
• Aphena Pharma Solutions, Inc.
• Bilcare Limited
• Constantia Flexibles Group GmbH
• Essentra plc
• Flexi Pack Limited
• Green Pack Foils

More Valuable Insights on Offer

Fact.MR, in its new offering, presents an unbiased analysis of the global cold form blister packaging market, presenting historical data for 2019 to 2023 and forecast statistics for 2024 to 2034.

The study reveals essential insights based on Material Type (Aluminium, Polyvinyl Chloride, Polypropylene, Oriented-polyamide, Other Material Types), Application (Pharmaceuticals, Consumer Products, Electronics & Semiconductors, Food & Confectionery, Other Applications), across major regions of the world (North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia & Pacific, Middle East & Africa).

Check out More Related Studies Published by Fact.MR Research:

Hearing Protection Device Market According to a recent industry analysis by Fact.MR, the global hearing protection device market size is valued at US$ 2.28 billion in 2023 and is forecasted to expand at a CAGR of 10.1% to reach a size of US$ 5.98 billion by the end of 2033.

Aseptic Packaging Market The global aseptic packaging market size is exhibiting remarkable growth and stands at a valuation of US$ 65.89 billion in 2023. The market is forecasted to expand at a CAGR of 10% and reach a size of US$ 170.9 billion by the end of 2033.

Reinsurance Market The global reinsurance market size is projected to expand at a steady CAGR of 4% and reach a valuation of US$ 598.85 billion by the end of 2033, up from US$ 404.56 billion in 2023.

Writing Instrument Market The global writing instrument market size is calculated at US$ 14.28 billion for 2024 and is projected to reach US$ 20.54 billion by 2034-end. Worldwide demand for writing instruments is projected to expand at a CAGR of 3.7% from 2024 to 2034.

Beauty Device Market The global beauty device market size is estimated at US$ 34.45 billion in 2024 and is forecasted to reach a size of US$ 107.95 billion by 2034-end, expanding at a high-value CAGR of 12.1% between 2024 and 2034.

Recovery Footwear Market Global demand for recovery footwear is projected to increase at a CAGR of 5.9% and reach a market value of US$ 28.76 billion by the end of 2034.

Closed Heel Nursing Shoes Market The global closed heel nursing shoes market size is estimated at a value of US$ 9.31 billion in 2024 and is forecasted to expand at a CAGR of 3.7% to reach US$ 13.39 billion by the end of 2034.

Smart Electric Heater Market A new study by Fact.MR reveals the global smart electric heater market size is pegged at US$ 1.86 billion for 2024. As per the report, global sales of smart electric heaters are predicted to rise at 13.8% CAGR and reach US$ 6.77 billion by the end of 2034.